Detalhe da pesquisa
1.
Genetic associations with sporadic neuroendocrine tumor risk.
Carcinogenesis
; 32(8): 1216-22, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21606320
2.
Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database.
Endocr Relat Cancer
; 20(2): 187-96, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23319495
3.
Prognostic significance of MTOR pathway component expression in neuroendocrine tumors.
J Clin Oncol
; 31(27): 3418-25, 2013 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23980085
4.
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Nat Genet
; 45(12): 1483-6, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24185511
5.
A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum.
Endocr Relat Cancer
; 18(1): 171-80, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21139019
6.
Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes.
Pharmacogenet Genomics
; 19(8): 613-25, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19620936